Financials / Press Releases

INVESTOR RELATIONS

BIOQUAL, Inc. is a public company traded on the OTC Markets Group – Symbol BIOQ.

BIOQUAL, Inc.’s Transfer Agent:

Computershare, Inc.
480 Washington Boulevard
Jersey City, New Jersey 07310
www.computershare.com

CONTACT:

Mark Lewis
President / Chief Executive Officer
BIOQUAL, Inc.
Phone: (240) 404-7654 ext. 1012

BIOQUAL Presents Unaudited Financial Statements and Management’s Discussion and Analysis for First Quarter of Fiscal Year 2020 Ending August 31, 2019 [Updated 10/21/19]

Press Release, 10/21/19, BIOQUAL, Inc. and Subsidiary Presents Unaudited Financial Results for First Quarter of Fiscal Year 2020

Mark Lewis Letter To Shareholders [09/20/19]

Management’s Discussion and Analysis Related to the Audited Financial Statements for Fiscal Year 2019 [Updated 09/13/19]

BIOQUAL, Inc. and Subsidiary Presents Audited Consolidated Financial Statements for Fiscal Year 2019 [Updated 09/13/19]

Press Release, 09/13/19, BIOQUAL, Inc. and Subsidiary Presents Financial Results for Fiscal Year 2019 and Declares Dividend

BIOQUAL Presents Unaudited Financial Results for FY 2019 Third Quarter Ending February 28, 2019 [Updated 04/16/19

Press Release, BIOQUAL, Inc. Presents Financial Results for FY 2019 Third Quarter [Updated 04/16/19]

In Memoriam, J. Thomas August, M.D. [Updated 02/22/19]

Press Release, 02/22/19, Death of J. Thomas August, M.D., a Member of the Board of Directors of BIOQUAL, Inc.

BIOQUAL Presents Financial Results for FY 2019 Second Quarter Ending November 30, 2018 [Updated 01/22/19]

Press Release, 01/22/19, BIOQUAL, Inc. and Subsidiary Presents Financial Results for Second Quarter of Fiscal Year 2019

Mark Lewis Letter To Shareholders [10/18/18]

Press Release, 09/11/18, BIOQUAL, Inc. and Subsidiary Presents Financial Results for Fiscal Year 2018 and Declares Dividend

BIOQUAL, Inc. and Subsidiary Presents Audited Financial Statements ending May 31, 2018 and 2017 [Updated 09/11/18]

Management’s Discussion and Analysis for the Fiscal Year ended 05/31/2018 [Updated 09/11/18]

Bioqual Announces Appointment of Dr. Vivek Patil to Board and Announces Results from 2018 Meeting of Stockholders [09/11/18]

Mark Lewis Letter To Shareholders [09/27/17]

Management’s Discussion and Analysis Related to the Audited Financial Statements for Fiscal Year 2017 [Updated 09/27/17]

BIOQUAL Presents Audited Financial Statements for Years Ended May 31, 2017 and 2016 [Updated 09/07/17]

Press Release, BIOQUAL, Inc. Presents Financial Results for FY 2017 and Declares Dividend [Updated 09/07/17]

Press Release, 04/27/17, BIOQUAL, Inc. announces the retirement of Dr. John C. Landon as Chairman of its Board of Directors and as a Director; The appointment of Mark G. Lewis, BIOQUAL’s President and Chief Executive Officer, as Chairman of the Board; and the election of David B. Landon, Ph.D., to fill the vacancy on the Board of Directors resulting from the retirement of Dr. John C. Landon

Mark Lewis Letter To Shareholders [12/28/15]

BIOQUAL, Inc., announces completion of the purchase of ABL’s In-Vivo Animal Model Services Related Assets by BIOQUAL and entry into Strategic Teaming Agreement. [Updated 02/27/14]

BIOQUAL, Inc. and ABL, Inc., Announce Agreement for the Sale of ABL’s In-Vivo Animal Model Services Related Assets to BIOQUAL and Strategic Teaming Agreement [Updated 12/09/13]

Press Release, Management Change Effective June 01, 2013 [Updated 06/05/13]

Please send mail to itdept@bioqual.com with questions or comments about this website.